Blog Posts

Julie Hallet: Defining High-risk Pancreas NETs

Julie Hallet/cpd.utoronto.ca

Aug 2, 2025, 09:25

Julie Hallet: Defining High-risk Pancreas NETs

Julie Hallet, Director of Research at Canadian Society of Surgical Oncology, shared a post on X:

“Defining high-risk pancreas NETs

496 resections

Early recurrence
71% if venous thrombosis
41% if Ki 67>5% + tumor >3cm + LN

Signs of biologically borderline-resectable NETs

before resection, start with systemic drugs.”

Julie Hallet

Title: Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk

Authors: Stefano Partelli, Giovanni Guarneri, Paola Rancoita, Ino De Martino, Lorenzo Provinciali, Louis De Mestier, Safi Dokmak, Julie Hallet, Alain Sauvanet, Massimo Falconi,

Read Full Article.

Julie Hallet

Read More About Pancreatic NETs on OncoDaily.

Alain Sauvanet cancer Giovanni Guarneri Ino De Martino Julie Hallet Lorenzo Provinciali Louis de Mestier Massimo Falconi OncoDaily Oncology Paola Rancoita Safi Dokmak Stefano Partelli

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter